Clinical Trials Logo

Clinical Trial Summary

This is a prospective, multi-center, open-label, single-arm feasibility trial to assess device safety and efficacy of the Cordella™ Heart Failure System in 10 NYHA Class III heart failure patients who will receive the Cordella™ Sensor implant.


Clinical Trial Description

The objectives of this study are to establish that the Cordella™ Sensor can be safely delivered, deployed, and remain stable within the target pulmonary artery (PA) segment through 30 days post-implant as well as to measure the accuracy of Cordella™ Sensor PA pressure measurements compared with fluid-filled catheter PA pressure measurements obtained by standard right heart catheterization (RHC) at 90 days post implant. Safety measures will include the frequency and rates of adverse events, both overall and for each specific event, which will be collected throughout the study. Subjects will remain in this trial for 24 months. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03375710
Study type Interventional
Source Endotronix, Inc.
Contact
Status Active, not recruiting
Phase N/A
Start date December 1, 2017
Completion date February 28, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT04452149 - Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure N/A
Withdrawn NCT03005184 - Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2 Phase 2
Not yet recruiting NCT01669395 - Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial N/A
Recruiting NCT05835063 - A Study to Improve Physician-Youth Communication and Medical Decision Making N/A
Completed NCT03895073 - HEart fAiluRe evaluaTion Questionnaire
Completed NCT03095196 - Multipolar CRT-d and Diabetes N/A
Recruiting NCT03180320 - Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study) N/A
Completed NCT06233695 - Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure
Withdrawn NCT03947853 - Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart Failure
Recruiting NCT05934487 - PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III N/A
Recruiting NCT04829617 - Promoting Well-being and Health in Heart Failure N/A
Recruiting NCT03538990 - Effect of DASH Eating Pattern on Heart Failure Outcomes N/A
Recruiting NCT05487365 - Implementation and Cost-evaluation of a Smartphone-based Telemonitoring and Digital Support in Patients With HF N/A
Not yet recruiting NCT06270875 - Addressing Pain Through Navigator-Led Palliative Care Optimized for Heart Failure (ADAPT-HF) N/A
Completed NCT03592836 - Diuretic Response in Advanced Heart Failure: Bolus Intermittent vs Continuous INfusion Phase 3
Not yet recruiting NCT06097481 - Narrative Intervention for Chronic Illness- Heart Failure Trial (NICI-HF) Phase 1/Phase 2
Completed NCT01560871 - Effects of a Walking Program and Inspiratory Muscle Training in Individuals With Chronic Heart Failure N/A
Completed NCT03387813 - Hemodynamic-GUIDEd Management of Heart Failure N/A
Enrolling by invitation NCT05885607 - Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure
Active, not recruiting NCT04012944 - SIRONA 2 Trial Heart Failure NYHA Class III N/A